Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
uMotif announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical ...
read more
EUROAPI has expanded its collaboration with Sanofi under the umbrella of their Master Agreement for Development and GMP Manufacturing Services (the “DSA”), dated October 1, 2021, to support Sanofi’s mRNA vaccine platform with the development of lipid...
read more
Lonza has enhanced its offering for customers in the early phases of their clinical trials by adding a dedicated Early Phase Clinical Manufacturing facility at its Small Molecules site in Bend, Oregon.
read more
Veranova, formerly known as Johnson Matthey Health, has launched as an independent company following the acquisition by Altaris Capital Partners, LLC from Johnson Matthey PLC.
Veranova is a global contract development and manufacturing organization ...
read more
Cambrex announced the acquisition of Q1 Scientific – a provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located in Waterford, Ireland.
read more
Evonik is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel ...
read more
Abzena Selects IPS for Turnkey Delivery of Their New CGMP Facility in North Carolina
IPS-Integrated Project Services, LLC, a provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its support to ...
read more
Vaxart, Inc. reported positive preliminary preclinical data demonstrating that two COVID-19 vaccine candidates targeting either the SARS-CoV-2 spike (S) protein for Wuhan or S protein for Omicron protected hamsters when challenged with the Omicron BA...
read more
Societal CDMO, Inc. has been selected by AmyriAD Pharma to provide CDMO services to support the ongoing clinical development of AD101. The compound, a novel T-type calcium channel modulator, is currently in clinical development for the treatment of ...
read more
IQVIA announced the appointment of Dr. Christina Mack to serve as chief scientific officer for the company’s Real World Solutions (RWS) business, effective July 7, 2022. Christina is succeeding Dr. Nancy Dreyer, who is retiring after nearly two ...
read more
DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, ...
read more
Berkeley Lights, Inc. and Curia, formerly AMRI, a contract research, development and manufacturing organization (CDMO), announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its ...
read more
Societal CDMO, Inc. announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility.
read more
Worldwide Clinical Trials, Inc. expanded its early phase clinical trial capabilities by opening its Bioanalytical Center of Excellence – a larger state-of-the-art lab in Austin, Texas.
read more
Curia, formerly AMRI, announced that they will collaborate on a robust development platform for Replicate’s srRNA therapeutics. The strategic collaboration unites two RNA therapeutics industry leaders.
read more